Ontology highlight
ABSTRACT:
SUBMITTER: Shuvaev AN
PROVIDER: S-EPMC9027563 | biostudies-literature | 2022 Apr
REPOSITORIES: biostudies-literature
Shuvaev Anton N AN Belozor Olga S OS Mozhei Oleg I OI Mileiko Aleksandra G AG Mosina Ludmila D LD Laletina Irina V IV Mikhailov Ilia G IG Fritsler Yana V YV Shuvaev Andrey N AN Teschemacher Anja G AG Kasparov Sergey S
Brain sciences 20220413 4
Memantine is an FDA approved drug for the treatment of Alzheimer's disease. It reduces neurodegeneration in the hippocampus and cerebral cortex through the inhibition of extrasynaptic NMDA receptors in patients and mouse models. Potentially, it could prevent neurodegeneration in other brain areas and caused by other diseases. We previously used memantine to prevent functional damage and to retain morphology of cerebellar neurons and Bergmann glia in an optogenetic mouse model of spinocerebellar ...[more]